Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium. At the event, the makers of technologies like pulsed field ablation (PFA) systems, left atrial appendage (LAA) devices, heart access catheters and more offered insights into how their therapies contribute to the treatment … [Read more...] about The biggest cardiac tech news out of the 2026 AF Symposium
Boston Scientific
Boston Scientific Farapulse PFA outperforms thermal ablation in study
Boston Scientific (NYSE:BSX) has announced new data backing its Farapulse pulsed field ablation (PFA) platform for treating AFib. Farapulse, a nonthermal treatment, uses electric fields to selectively ablate heart tissue. It's one of the leading PFA systems in a market that includes Medtronic, Johnson & Johnson … [Read more...] about Boston Scientific Farapulse PFA outperforms thermal ablation in study
Boston Scientific has a potentially serious Axios stent recall
The FDA has flagged a Boston Scientific recall of its Axios stent and delivery system as potentially serious. The recall involves problems with stent deployment and expansion, according to the notice that the FDA published on Jan. 16. Regulatory reports in countries including the U.K. and Malaysia say the issues were associated with … [Read more...] about Boston Scientific has a potentially serious Axios stent recall
Boston Scientific to acquire Penumbra for $14.5B
Boston Scientific (NYSE: BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker Penumbra (NYSE:PEN). The deal values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion. Penumbra shares currently trade at approximately $313.43 apiece ahead of the market opening … [Read more...] about Boston Scientific to acquire Penumbra for $14.5B
Boston Scientific reports first peripheral cases in Seismiq IVL rollout
A Boston Scientific (NYSE: BSX) today took to social media to share news of the first peripheral cases using its Seismiq system. Boston Scientific President, Peripheral Vascular, Catherine Jennings, wrote on LinkedIn that the company is "celebrating an important milestone" with the completion of the first peripheral cases using the intravascular … [Read more...] about Boston Scientific reports first peripheral cases in Seismiq IVL rollout
Boston Scientific wins FDA nod for Farapoint PFA catheter
A Boston Scientific (NYSE:BSX) executive said on social media that the company received FDA approval for its Farapoint pulsed field ablation (PFA) catheter. SVP and President of Electrophysiology, Nick Spadea-Anello, posted on LinkedIn to congratulate the company for receiving FDA approval for Farapoint. He noted that the approval "closely … [Read more...] about Boston Scientific wins FDA nod for Farapoint PFA catheter
Boston Scientific gets European nod for Farapoint catheter
Boston Scientific announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) catheter. The regulatory nod, earned last week, allows the Marlborough, Massachusetts-based company to bring the newest PFA catheter in its electrophysiology portfolio to the European market. Farapoint treats right atrial flutter (AFL), … [Read more...] about Boston Scientific gets European nod for Farapoint catheter
CMS adds reimbursement for cardiac ablation in ASCs
The Centers for Medicare and Medicaid Services (CMS) has provided a major reimbursement update for cardiac ablation technologies. In its 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, CMS added cardiac catheter ablation procedures to its ASC-covered procedures list. This … [Read more...] about CMS adds reimbursement for cardiac ablation in ASCs
Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal
Boston Scientific [WtwhTicker symbol="BSX"](NYSE: BSX)[/WtwhTicker] today announced a catheter development and commercialization deal with Siemens Healthineers. The deal centers around the workflow development and commercialization of Siemens Healthineers' AcuNav 4D intracardiac echocardiography (ICE) catheter. AcuNav 4D ICE technology is … [Read more...] about Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal
Boston Scientific enrolls first patient in AFib mapping study using OptiMap, Farapulse
A Boston Scientific [WtwhTicker symbol="BSX"](NYSE: BSX)[/WtwhTicker] official announced the enrollment of the first patients in the OPTIMIZE randomized controlled clinical trial. On LinkedIn, Nick Spadea-Anello, the company’s president of Electrophysiology, announced the enrollment in the trial. He said Dr. Oussama Wazni, global principal … [Read more...] about Boston Scientific enrolls first patient in AFib mapping study using OptiMap, Farapulse
